4-Bromo-2,1,3-benzothiadiazole(CAS: 22034-13-5)

4-Bromo-2,1,3-benzothiadiazole (CAS: 22034-13-5) is subject to regulations such as REACH (Registration, Evaluation, Authorization, and Restriction of Chemicals) in the European Union, which requires suppliers to register and provide safety data sheets (SDS). It is also subject to GHS (Globally Harmonized System of Classification and Labeling of Chemicals) classification for hazardous properties, and may be regulated by the EPA and FDA in the United States for specific applications.

For synthesis purposes, alternatives to 4-Bromo-2,1,3-benzothiadiazole (CAS: 22034-13-5) include other substituted benzothiadiazoles or analogs like 2,1,3-benzothiadiazole-4-carbaldehyde, which can serve similar functional groups in organic synthesis. Other reagents such as bromoacetic acid can be used as a starting material for related compounds.

The market for 4-Bromo-2,1,3-benzothiadiazole (CAS: 22034-13-5) is driven by its use in pharmaceuticals and materials science. Research trends focus on its application in antimicrobial agents and as a precursor in the synthesis of other compounds. Market trends show increasing demand, particularly in the pharmaceutical industry due to its broad spectrum of antimicrobial activity.

Waste containing 4-Bromo-2,1,3-benzothiadiazole (CAS: 22034-13-5) should be collected in appropriate containers and stored under conditions that prevent spillage and exposure. Professional waste disposal services should be utilized for incineration or other safe destruction methods. Environmental protection measures include ensuring that waste does not enter water systems and that disposal follows local and international regulations.